Back to today’s briefing

Story perspectives

Novo Nordisk to Sell Wegovy via Hims & Hers Partnership

3/7/2026

38 4 Full Breakdown

Summary

Story summary

Novo Nordisk plans to sell Wegovy on the Hims & Hers Health platform, ending the patent dispute.
The partnership announcement is expected soon.
Novo Nordisk emphasized ongoing discussions with companies to improve access to Food and Drug Administration (FDA)-approved medicines.
Last month, Novo Nordisk sued Hims after it marketed a copy of Wegovy.
This action ended the previous partnership due to Hims' marketing tactics.

1 of 1

Story summary

Novo Nordisk plans to sell Wegovy on the Hims & Hers Health platform, ending the patent dispute.
The partnership announcement is expected soon.
Novo Nordisk emphasized ongoing discussions with companies to improve access to Food and Drug Administration (FDA)-approved medicines.
Last month, Novo Nordisk sued Hims after it marketed a copy of Wegovy.
This action ended the previous partnership due to Hims' marketing tactics.